Viewing StudyNCT00513513



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00513513
Status: TERMINATED
Last Update Posted: 2010-04-26
First Post: 2007-08-06

Brief Title: TMC114-C227 A Study to Evaluate the Effectiveness and Safety of TMC114 Darunavir With a Low Dose of Ritonavir as Monotherapy no Other Anti-HIV Drugs Will be Given in Patients Who Have Never Been Treated With Antiretrovirals Anti-HIV Drugs Previously
Sponsor: Tibotec Pharmaceuticals Ireland
Organization: Tibotec Pharmaceuticals Ireland

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Treatment Naive View
HIV View
AIDS View
TMC114 View
Protease inhibitor View
Darunavir View
Antiretroviral agents View